Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Pipeline
Cancer Program
Fibrosis Program
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Announcements and Reports
Home
>
Announcements and Reports
>
ASX Announcements
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
ASX Announcements
Filter by Year:
2023
2022
2021
2020
2019
2018
4-Dec-2023
Approval to Initiate Phase2 Pancreatic Cancer Trial in Korea
21-Nov-2023
Appendix 4D and Financial Report Half Year ended 30 Sep 23
31-Oct-2023
Quarterly Activities/Appendix 4C Cash Flow Report
30-Oct-2023
Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer
19-Oct-2023
Amplia Receives R&D Tax Rebate Totalling $ 2.4 Million
9-Oct-2023
AACR Ovarian Cancer Conference Presentation
29-Sep-2023
AACR Pancreatic Cancer Conference Presentation
25-Sep-2023
New Chief Financial Officer Mr Tim Luscombe
4-Sep-2023
Notification of cessation of securities - ATX
1-Sep-2023
Notification of cessation of securities - ATX
1
2
3
4
Next
